Trial Condition(s):

Angina Pectoris, Postmenopause, Hormone Replacement Therapy

Study to evaluate the effect of 1 mg Estradiol and 2 mg Drospirenone over 6 weeks on the coronary flow reserve of postmenopausal women with angina pectoris

Bayer Identifier:

90832

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
60
Trial Dates
black-arrow
Phase
2
Could I receive a placebo?
No
Products
Angeliq (E2/DRSP, BAY86-4891)
Accepts Healthy Volunteers
N/A

Where to Participate

Locations
Status
LocationsStatus

Trial Design